Abstract
A wide variety of cerebrovascular disorders can complicate the clinical course of cancer patients and, in rare instances, can be the presenting sign of cancer. Central nervous system (CNS) hemorrhage and ischemic events are typically symptomatic. Hemorrhage can occur into the parenchymal, subdural, epidural, or subarachnoid compartments and usually presents with symptoms typical for those sites. Cerebral infarction may cause focal signs, presenting as a transient ischemic attack (TIA) or infarction, or may cause encephalopathy when there are multiple and progressive small infarctions. The most common mechanisms of cerebrovascular disease in cancer patients are related to the presence of CNS tumor, either primary or metastatic, and coagulopathy. The coagulopathy in many instances is a direct effect of the neoplasm; in other cases it develops from cancer treatment. Cancer treatment can also result in blood vessel injury. Radiation therapy directed to the neck or brain can result in vessel stenosis, thrombosis and other vascular pathologies. Chemotherapy and molecularly-targeted agents can lead to vascular injury or thrombosis resulting in hemorrhage or infarction. Infection is a less common cause of stroke. It is important to identify cerebrovascular disease as the cause of neurologic symptoms in the cancer patient in order to determine appropriate evaluation and treatment. This is usually possible by a careful review of the cancer histology and sites of disease, types of antineoplastic therapy administered, and associated comorbidities. Laboratory studies of coagulation function and CNS imaging techniques are useful in identifying the precise etiology of the cerebrovascular disorder. Prompt diagnosis leads to appropriate therapy that, in certain patients, can improve the quality of life and survival as well as prevent additional vascular episodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine. 1985;64:16–35.
Zoller B, Sundquist JJ, Sundquist K. Risk of haemorrhagic and ischemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48:1875–83.
Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology. 2010;74:494–501.
Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: Incidence and etiology. Neurology. 2004;62:2025–30.
Noji C, Cohen K, Jordan LC. Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013;49:1875–83.
Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis. 2008;17:169–74.
Kneihsl M, Enzinger C, Wunsch G, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263:150–6.
Schrader B, Barth H, Lang EW. Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien). 2000;142:979–85.
Abraham NA, Prayson RA. The role of histopathologic examination of intracranial blood clots removed for hemorrhage of unknown etiology: a clinical pathologic analysis of 31 cases. Ann Diagn Pathol. 2000;4:361–6.
Yuguang L, Meng L, Shugan Z, et al. Intracranial tumoural haemorrhage—a report of 58 cases. J Clin Neurosci. 2002;9:637–9.
Jiang XB, Ke C, Zhang GH, et al. Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer. 2012;12:49.
Liwnicz BH, Wu SZ, Tew JM. The relationship between the capillary structure and hemorrhage in gliomas. J Neurosurg. 1987;66:536–41.
Bosnjak R, Derham C, Popović M, Ravnik J. Spontaneous intracranial meningioma bleeding: clinicopathological features and outcome. J Neurosurg. 2005;103:473–84.
Katz JM, Segal AZ. Incidence and etiology of cerebrovascular disease in patients with malignancy. Curr Atheroscler Rep. 2005;7:280–8.
Jung S, Moon K-S, Jung T-Y, et al. Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage. J Neurooncol. 2006;76:257–63.
Atlas SW, Grossman RI, Gomori JM, et al. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology. 1987;164:71–7.
Kamel H, Navi BB, Hemphill C. A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage. Neurocrit Care. 2013;1:59–63.
Boellis A, diNapoli A, Romano A, Bozzao A. Pituitary apoplexy: an update on clinical and imaging features. Insights Imaging. 2014;5:753–62.
Singh TD, Valizadeh N, Meyer FB, Atkinson JL, Erickson D, Rabinstein AA. Management and outcomes of pituitary apoplexy. J Neurosurg. 2015;122:1450–7.
Reichman J, Singer S, Navi B, et al. Subdural hematoma in patients with cancer. Neurosurgery. 2012;71:74–9.
Laigle-Donadey F, Taillibert S, Mokhtari K, et al. Dural metastases. J Neurooncol. 2005;75:57–61.
Hata A, Fujita S, Katakami N, Sakai C, Imai Y. Bilateral subdural hematoma associated with central nervous system metastasis from lung cancer. J Thorac Oncol. 2011;6:207–8.
Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology. 2000;54:1222–6.
Oda N, Sakugawa M, Bessho A, et al. Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptor-mutated lung cancer. Oncol Lett. 2014;8:2489–92.
Zheng J, Zhang J. Neoplastic cerebral aneurysm from metastatic tumor: a systematic review of clinical and treatment characteristics. Clin Neurol Neurosurg. 2015;128:107–11.
Nomura R, Yoshida D, Kim K, Kobayashi S, Teramoto A. Intracerebral hemorrhage caused by a neoplastic aneurysm from pleomorphic lung carcinoma. Neurol Med Chir (Tokyo). 2009;49:33–6.
Gutmann DH, Cantor CR, Piacente GJ, McCluskey LF. Cerebral vasculopathy and infarction in a woman with carcinomatous meningitis. J Neurooncol. 1990;9:183–5.
Herman C, Kupsky WJ, Rogers L, Duman R, Moore P. Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis. Stroke. 1995;26:2366–70.
Artoni A, Bucciarelli P, Martinelli I. Cerebral thrombosis and myeloproliferative neoplasms. Curr Neurol Neurosci Rep. 2014;14:496.
Enblom A, Lindskog E, Hasselbalch H, et al. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms. Eur J Intern Med. 2015;26:344–7.
Koenig MK, Sitton CW, Wang M, Slopis JM. Central nervous system complications of blastic hyperleukocytosis in childhood acute lymphoblastic leukemia: diagnostic and prognostic implications. J Child Neurol. 2008;23:1347–52.
Pham HP, Schwartz J. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis. Transfusion. 2015;55:2306–11.
Ferro A, Jabbour SK, Taunk NK, et al. Cranial irradiation in adults diagnosed with acute myelogenous leukemia presenting with hyperleukocytosis and neurologic dysfunction. Leuk Lymphoma. 2014;55:105–9.
Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3:1010–24.
Baehring JM, Henchcliffe C, Ledezma CH, Fulbright R, Hochberg FH. Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system. J Neurol Neurosurg Psychiatry. 2005;76:540–4.
Dias RR, Fernandes F, Ramires FJ, Mady C, Albuquerque CP, Jatene FB. Mortality and embolic potential of cardiac tumors. Arq Bras Cardiol. 2014;103:13–8.
Abraham KP, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol. 1990;3:195–8.
Navi BB, Kawaguchi K, Hriljac I, et al. Multifocal stroke from tumor emboli. Arch Neurol. 2009;66:1174–5.
Spaulding R, Koumoundouros T, Parker JC. Metastatic undifferentiated pleomorphic sarcoma causing intraoperative stroke. Ann Clin Lab Sci. 2013;43:172–5.
Schwarzbach CJ, Schaefer A, Ebert A, et al. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke. 2012;43:3029–34.
Yusuf SW, Ali SS, Swafford J, et al. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994–2004. Medicine (Baltimore). 2006;85:86–94.
Merkler AE, Navi BB, Singer S, et al. Diagnostic yield of echocardiography in cancer patients with ischemic stroke. J Neurooncol. 2015;123:115–21.
Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33:1267–73.
Lafitte F, Boukobza M, Guichard JP, et al. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis. Clin Radiol. 1997;52:672–9.
Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600.
De Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;304:484–8.
Santoro N, Giordano P, Del Vecchio GC, et al. Ischemic stroke in children treated for acute lymphoblastic leukemia. A retrospective study. J Pediatr Hematol Oncol. 2005;27:153–7.
Ranta S, Tuckuviene R, Makipernaa A, et al. Cerebral venous thromboses in children with acute lymphoblastic leukaemia—a multicenter study from the Nordic Society of Paediatric Haematology and Oncology. Br J Haematol. 2015;4:547–52.
Choudhri O, Feroze A, Marks MP, Do HM. Endovascular management of cerebral venous sinus thrombosis. Neurosurg Focus. 2014;37(Suppl 1):1.
Viegas LD, Stolz E, Canhão P, Ferro JM. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review. Cerebrovasc Dis. 2014;37:43–50.
Gonzalez Quintela A, Candela MJ, Vidal C, et al. Nonbacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46:1–9.
Rogers LR, Cho E, Kempin S, et al. Cerebral infarction from nonbacterial thrombotic endocarditis. Am J Med. 1987;83:746–58.
Min KW, Gyorkey F, Sato C. Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: pathogenic role of tumor mucin. Cancer. 1980;45:2374–82.
Biller J, Challa VR, Toole JF, et al. Nonbacterial thrombotic endocarditis: a neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982;39:95–8.
Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology. 1989;39:522–6.
Bernardo MC, Menke J, Scheithauer B, et al. Intravascular mucinosis: a rare cause of cerebral infarction. Acta Neuropathol. 2011;121:785–8.
Towfighi J, Simmonds MA, Davidson EA. Mucin and fat emboli in mucinous carcinomas. Cause of hemorrhagic cerebral infarcts. Arch Pathol Lab Med. 1983;107:646–9.
Arkel YS. Thrombosis and cancer. Semin Oncol. 2000;27:362–74.
Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586–92.
Mantha S, Tallman M, Soff GA. What’s new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia? Curr Opin Hematol. 2016;23(2):121–6.
Sallah S, Wan JY, Nguyen NP, et al. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2011;86:828–33.
Sakuragawa N, Hasegawa H, Maki M, et al. Clinical evaluation of low-molecular-weight–heparin (FR-860) on disseminated intravascular coagulation (DIC): a multicenter co-operative, double-blind trial in comparison with heparin. Thromb Res. 1993;72:475–500.
Avvisati G, ten Cate JW, Buller HR, et al. Tranexamic acid for control of hemorrhage in acute promyelocytic leukaemia. Lancet. 1989;2:122–4.
Lechner K, Obermeier HL. Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore). 2012;91:195–205.
Kaden BR, Rosse WF, Hauch TW. Immune thrombocytopenia in lymphoproliferative diseases. Blood. 1979;53:545–51.
Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost. 1999;25:217–21.
Omura M, Aida N, Sakido K, et al. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1997;38:241–9.
Fouladi M, Langston J, Mulhern R, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol. 2000;18:824–31.
Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:5277–82.
Fullerton HJ, Stratton K, Mueller S, et al. Recurrent stroke in childhood cancer survivors. Neurology. 2015;85:1–9.
Bowers DC, Mulne AF, Reisch JS, et al. Nonperioperative strokes in children with central nervous system tumors. Cancer. 2002;94:1094–101.
Campen CJ, Kranick SM, Kasner SE, et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke. 2012;43:3035–40.
Aizer AA, Du R, Wen PY, Arvold ND. Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors. J Neurooncol. 2015;124:291–7.
Van Varsseveld NC, van Bunderen CC, Ubachs DH, et al. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch national registry of growth hormone treatment in adults. J Clin Endocrinol Metabl. 2015;100:1104–12.
Nanney AD, El Tecle NE, El Ahmadieh TY, et al. Intracranial aneurysms in previously irradiated fields: literature review and case report. World Neurosurg. 2014;81:511–9.
Kellner CP, McDowell MM, Connolly ES Jr, Sisti MB, Lavine SD. Late onset aneurysm development following radiosurgical obliteration of a cerebellopontine angle meningioma. BMJ Case Rep. 2014; 14. pii: bcr2014011206.
Matsumoto H, Minami H, Yamaura I, Oshida Y. Radiation-induced cerebal aneurysm treated with endovascular coil embolization. INR. 2014;20:448–53.
Li L, Mugikara AS, Kumabe T, et al. A comparative study of the extent of cerebral microvascular injury following whole-brain irradiation versus reduced-field irradiation in long-term survivors of intracranial germ cell tumors. Radiother Oncol. 2015;117:302–7.
Koike S, Aida N, Hata M, Fujita K, Ozawa Y, Inoue T. Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: frequency, latency, and dose relation. Radiology. 2004;230:93–9.
Singla A, Brace O’Neill JE, Smith E, Scott RM. Cavernous malformations of the brain after treatment for acute lymphocytic leukemia: presentation and long-term follow-up. J Neurosurg Pediatr. 2013;11:127–32.
Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus. 2006;21:e4.
Di Giannatale A, Morana G, Rossi A, et al. Naural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy. J Neurooncol. 2014;117:311–20.
Yoshino M, Morita A, Shibahara J, Kirino T. Radiation-induced spinal cord cavernous malformation. Case report. J Neurosurg. 2005;102(Suppl 1):101–4.
Koike T, Yanagimachi N, Ishiguro H, et al. High incidence of radiation-induced cavernous hemangioma in long-term survivors who underwent hematopoietic stem cell transplantation with radiation therapy during childhood or adolescence. Biol Blood Marrow Transplant. 2012;18:1090–8.
Desai SS, Paulino AC, Mai WY, Teh BS. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006;65:1222–7.
Dorresteijn LD, Kappelle AC, Boogerd W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20:282–8.
Dorth JA, Patel PR, Broadwater G, Brizel DM. Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. Head Neck. 2014;36:215–9.
Gujral DM, Shah BN, Chahal NS, et al. Do traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients? QJM. 2016;109(6):383–9.
Bashar K, Healy D, Clarke-Moloney M, et al. Effects of neck radiation therapy on extra-cranial carotid arteries atherosclerosis disease prevalence: systematic review and a meta-analysis. PLoS ONE. 2014;9:e110389.
Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin’s disease: a report from the childhood cancer survivor study. J Clin Oncol. 2005;23:6508–15.
Black DF, Morris JM, Lindell EP, et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible. AJNR. 2013;34:2298–303.
Sano N, Satow T, Maruyama D, et al. Carotid endarterectomy carries less risk than stenting in patients with radiation-induced carotid stenosis. J Vasc Surg. 2015;62:370–7.
Cam A, Shishehbor MH, Bajaj NS, et al. Outcomes of carotid stenting in patients with previous neck radiation. Catheter Cardiovasc Interv. 2013;82:689–95.
Ravin RA, Gottlieb A, Pasternac K, et al. Carotid artery stenting may be performed safely in patients with radiation therapy-associated carotid stenosis without increased restenosis or target lesion revascularization. JVS. 2015;62:624–30.
Brinjikji W, Cloft HJ. Outcomes of endovascular occlusion and stenting in the treatment of carotid blowout. Interv Neuroradiol. 2015;21:543–7.
Brown DV, Faber LP, Tuman KJ. Perioperative stroke caused by arterial tumor embolism. Anesth Analg. 2004;98:806–9.
Cho Y, Hida Y, Kaga K, Kato H, Iizuka M, Kondo S. Brain metastases secondary to tumor emboli from primary lung cancer during lobectomy. Ann Thorac Surg. 2008;86:312–3.
MacNeil SD, Liu K, Garg AX, Tam S, et al. A population-based study of 30-day incidence of ischemic stroke following surgical neck dissection. Medicine (Baltimore). 2015;94:e1106.
Garza-Ramos RDl, Kerezoudis P, Tarmago RJ, et al. Surgical complications following malignant brain tumor surgery: an analysis of 2002–2011 data. Clin Neurol Neurosurg. 2015;140:6–10.
Gempt J, Gerhardt J, Toth V, et al. Postoperative ischemic changes following brain metastasis resection as measured by diffusion-weighted magnetic resonance imaging. J Neurosurg. 2013;119:1395–400.
Jakola AS, Berntsen EM, Christensen P, et al. Surgically acquired deficits and diffusion weighted MRI changes after glioma resection—a matched case-control study with blinded neuroradiological assessment. J Neurosurg. 2013;119:829–36.
Smith JS, Cha S, Mayo MC, et al. Serial diffusion–weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg. 2005;103:428–38.
Gempt J, Krieg SM, Hüttinger S, et al. Postoperative ischemic changes after glioma resection identified by diffusion-weighted magnetic resonance imaging and their association with intraoperative motor evoked potentials. J Neurosurg. 2013;119:829–36.
Friedman JA, Piepgras DG, Duke DA, et al. Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery. 2001;49:1327–40.
Keiper GL, Sherman JD, Tomsick TA, et al. Dural sinus thrombosis and pseudotumor cerebri: unexpected complications of suboccitpital craniotomy and translabyrinthine craniectomy. J Neurosurg. 1999;91:192–7.
Quarante LH, Mena-Bernal JH, Martin BP, et al. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature. Childs Nerv Syst. 2016;32(5):857–63.
Burkhardt JK, Riina HA, Shin BJ, Moliterno JA, Hofstetter CP, Boockvar JA. Intra-arterial chemotherapy for malignant gliomas: a critical analysis. Interv Neuroradiol. 2011;17:286–95.
Kallmes DF, Evans AJ, Kaptain GJ, et al. Hemorrhagic complications in embolization of a meningioma: case report and review of the literature. Neuroradiology. 1997;39:877–80.
Shah A, Choudhari O, Jung H, Li G. Preoperative endovascular embolization of meningiomas: update on therapeutic options. Neurosurg Focus. 2015;38:e7.
Lee AY, Levine MN. The thrombophilic state induced by therapeutic agents in the cancer patient. Semin Thromb Hemost. 1999;25:137–45.
Bushman JE, Palmierir D, Whinna HC, et al. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia. Leuk Res. 2000;24:559–65.
Gugliotta L, Mazzucconi MG, Leone G, et al. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving l–aspariginase during induction therapy: a retrospective study. Eur J Haematol. 1992;49:63–6.
Koppelmans V, Vernooij MW, Boogerd W, et al. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and ehemotherapy. J Clin Oncol. 2015;33:588–93.
Patel SB, Gojo I, Tidwell ML, Sausvile EA, Baer MR. Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy. Leuk Lymphoma. 2011;52:1011–4.
Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036–42.
Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior reversible encephalopathy syndrome in patients with cancer. Oncologist. 2015;20:806–11.
Hamo CE, Bloom MW. Getting to the heart of the matter: an overview of cardiac toxicity related to cancer therapy. Clin Med Insights Cardiol. 2015;9(Suppl 2):47–51.
Bloom MW, Hamo CE, Cardinale D, et al. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk Factors, and imaging. Circ Heart Fail. 2016;9:e002661.
Dietrich U, Hettmann M, Maschke M, et al. Cerebral aspergillosis: comparison of radiological and neuropathologic findings in patients with bone marrow transplantation. Eur Radiol. 2001;11:1242–9.
Gabelmann A, Klein S, Kern W, et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol. 2007;14:548–55.
Starkey J, Moritani T, Kirby P. MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol. 2014;24:217–30.
Jo JT, Schiff D, Perry JR. Thrombosis in brain tumors. Semin Thromb Hemost. 2014;40:325–31.
Norden AD, Bartolomeo J, Tanaka S, et al. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients. J Neurooncol. 2012;106:121–5.
Coplin WM, Cochran MS, Levine SR, et al. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain. 2001;124:1043–51.
Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology. 1996;46:1004–9.
Colosimo M, McCarthy N, Jayasinghe R, et al. Diagnosis and management of subdural haematoma complicating bone marrow transplantation. Bone Marrow Transplant. 2000;25:549–52.
Bleggi-Torres LF, Werner B, Gasparetto EL, et al. Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients. Bone Marrow Transplant. 2002;29:29–32.
Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant. 1998;22:351–7.
Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant. 1994;14:495–504.
Le Guennec L, Roos-Weil D, Mokhtari K, et al. Granulomatous angiitis of the CNS revealing a Hodgkin lymphoma. Neurology. 2013;80:323–4.
Kalafut M, Vinuela F, Saver JL, et al. Multiple cerebral pseudoaneurysms and hemorrhages: the expanding spectrum of metastatic cerebral choriocarcinoma. J Neuroimaging. 1998;8:44–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Rogers, L.R. (2018). Cerebrovascular Complications of Cancer. In: Schiff, D., Arrillaga, I., Wen, P. (eds) Cancer Neurology in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-319-57901-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-57901-6_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57899-6
Online ISBN: 978-3-319-57901-6
eBook Packages: MedicineMedicine (R0)